Ye Liu
Impact in
- Neurology top 2%
- Myasthenia Gravis and Thymoma
Papers in
- Oncology 12
- Colorectal Cancer Treatments and Studies 3
- Colorectal Cancer Surgical Treatments 2
-
- Gut microbiota and health 4
- Melanoma and MAPK Pathways 3
- Co-authors
- Michael V. Cohen (1 shared paper)James M. Downey (1 shared paper)Akihito Tsuchida (1 shared paper)Xiaogang Wu (2 shared papers)Jiuyu Du (2 shared papers)Haiyan Gong (2 shared papers)Ziyou Song (1 shared paper)Guoliang Wu (1 shared paper)
- Journals
- Journal of Investigative Dermatology (4 papers)European Journal of Pharmacology (3 papers)European Journal of Orthodontics (2 papers)Frontiers in Pharmacology (2 papers)Behavioural Brain Research (2 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Ye Liu
87 papers receiving 2.9k citations
Ye Liu's Hit Papers
Peers
Comparison fields: 5 of 127
- Neurology 528
- Energy Engineering and Power Technology 49
- Pathology and Forensic Medicine 265
- Cancer Research 164
- Ophthalmology 109
Countries citing papers authored by Ye Liu
This map shows the geographic impact of Ye Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ye Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ye Liu more than expected).
Fields of papers citing papers by Ye Liu
This network shows the impact of papers produced by Ye Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ye Liu. The network helps show where Ye Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Ye Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 92 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study Hit paper breakdown → | 2017 | 632 |
| 2 | 1994 | 233 | |
| 3 | 2019 | 182 | |
| 4 | 2019 | 173 | |
| 5 | 2015 | 138 | |
| 6 | 2015 | 94 | |
| 7 | 2019 | 88 | |
| 8 | 2022 | 85 | |
| 9 | 2022 | 75 | |
| 10 | 2019 | 72 | |
| 11 | 2013 | 58 | |
| 12 | 2019 | 51 | |
| 13 | 2019 | 46 | |
| 14 | 2016 | 44 | |
| 15 | Erianin inhibits the proliferation of T47D cells by inhibiting cell cycles, inducing apoptosis and suppressing migration. | 2016 | 42 |
| 16 | 2019 | 42 | |
| 17 | 2016 | 38 | |
| 18 | 2009 | 37 | |
| 19 | 2021 | 35 | |
| 20 | 2017 | 33 |
About Ye Liu
Ye Liu is a scholar working on Oncology, Molecular Biology, Cancer Research, Ophthalmology and Cell Biology, having authored 92 papers that have together received 3k indexed citations. Recurring topics across this work include Gut microbiota and health (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Melanoma and MAPK Pathways (3 papers), Acute Kidney Injury Research (2 papers), Colorectal Cancer Surgical Treatments (2 papers), Adipose Tissue and Metabolism (2 papers), Obstructive Sleep Apnea Research (2 papers) and Lung Cancer Treatments and Mutations (2 papers). The work is most often cited by research in Neurology (528 citations), Energy Engineering and Power Technology (49 citations), Pathology and Forensic Medicine (265 citations), Cancer Research (164 citations) and Ophthalmology (109 citations). Ye Liu has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Michael V. Cohen, James M. Downey, Akihito Tsuchida, Xiaogang Wu, Jiuyu Du, Haiyan Gong, Ziyou Song, Guoliang Wu, Na Liu and Zhonghua Ma. Their work appears in journals such as Journal of Investigative Dermatology, European Journal of Pharmacology, European Journal of Orthodontics, Frontiers in Pharmacology and Behavioural Brain Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.